Close

After-Hours Movers 01/09: (LXRX) (ELX) (CRUS) Higher; (LIZ) (WDFC) (SMSC) (TRNO) (JNPR) Lower

January 9, 2012 7:03 PM EST
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) 14% HIGHER; announced today top-line results from the first clinical study testing the combined effects of LX4211, a novel sodium glucose transporter 1 and 2 (SGLT1 and SGLT2) inhibitor, with the dipeptidyl peptidase 4 (DPP-4) inhibitor, sitagliptin (Januvia®). Results from the study in 18 patients with type 2 diabetes showed that single doses of LX4211, a dual inhibitor of SGLT1 and SGLT2, in combination with sitagliptin, produced lower blood glucose levels after meals (postprandial) as compared to treatment with sitagliptin alone (p=0.012). Click here to see the full report.

Liz (NYSE: LIZ) 11.9% LOWER; announces its CFO Andrew Warren will be leaving the company. Sees FY11 adj-EBITDA at the low end of its $80-$90 million range. Cuts its FY12 adj-EBITDA outlook from $130-$150 million to $125-$140 million.

Emulex (NYSE: ELX) 8% HIGHER; offers preliminary Q2 sales of $127-$128 million and adj-EPS of 24-25 cents. The Street is currently expecting Q2 sales of $124 million and EPS of 17 cents. Emulex had previously guided Q2 sales to $121-$127 million and EPS to 17-20 cents.

WD-40 Co (NASDAQ: WDFC) 7.7% LOWER; reported Q1 EPS of $0.42, $0.12 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $84.9 million versus the consensus estimate of $86.13 million.

Cirrus Logic (Nasdaq: CRUS) 7.3% HIGHER; posts Q3 preliminary sales of $122 million, which compares to the Street estimate of $105.08 million. Sees Q4 sales of $105 million, which compares to the Street estimate of $98.5 million.

Standard Microsystems Corp (NASDAQ: SMSC) 6.8% LOWER; reported Q3 adjusted EPS of $0.21, $0.12 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $106.2 million versus the consensus estimate of $107.56 million. Standard Microsystems Corp sees Q4 2012 revenue of $89-$93 million, versus the consensus of $104.5 million.

Terreno Realty Corporation (NYSE: TRNO) 5.8% LOWER; plans to sell 4,000,000 shares of its common stock in an underwritten public offering pursuant to its effective shelf registration statement previously filed with the Securities and Exchange Commission. The underwriters will be granted a 30-day option to purchase up to an additional 600,000 shares of common stock.

Crestwood Midstream Partners LP (NYSE: CMLP) 4.2% LOWER; has commenced a public offering of 3,250,000 common units under its effective shelf registration statement. Crestwood intends to use the net proceeds from the offering to reduce the indebtedness outstanding under its revolving credit facility. Wells Fargo Securities, Barclays Capital, Citigroup, RBC Capital Markets and UBS Investment Bank are acting as joint book-running managers for the offering.

Ocz Technology Group, Inc. (NASDAQ: OCZ) 3.7% LOWER; reported Q3 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $103.1 million versus the consensus estimate of $99.5 million. Sees Q4 2012 revenue of $105-$120 million, versus the consensus of $106.30 million. Sees FY2012 revenue of $360-$375 million, versus the consensus of $358.02 million.

Measurement Specialties (Nasdaq: MEAS) 3.3% LOWER; sees Q3 net organic sales of about $69 million. Sees Q4 sales of $81-$84 million, which compares to the Street estimate of $85.3 million. Cuts its FY12 sales guidance from $313-$318 million to $308-$311 million. The Street is currently expecting FY12 sales of $315.4 million.

Juniper (Nasdaq: JNPR) 3% LOWER; cuts Q4 EPS from 32-36c to 26-28c, vs. cons. 34c; sales from $1.16-$1.22B to $1.11-$1.12B, vs. cons. $1.19B.

ARMOUR Residential REIT, Inc. (NYSE: ARR) 2.5% LOWER; is commencing an underwritten public offering of 9,000,000 shares of common stock. ARMOUR expects to grant the underwriter a 30-day option to purchase up to 1,350,000 additional shares of common stock.

Genesco Inc. (NYSE: GCO) 1.4% HIGHER; reports same-store sales rose 13 percent in December. Based on the stronger than expected sales for the quarter to date, the Company has increased its adjusted earnings per diluted share expectations to a range of $1.63 to $1.68 for the fourth quarter and $3.74 to $3.79 for the fiscal year ending January 28, 2012. The Company's most recent previously announced earnings expectations were in the range of $1.53 to $1.58 per diluted share for the fourth quarter and $3.64 to $3.69 for the fiscal year. The Street sees Q4 EPS of $1.60 and FY11 EPS of $3.71.

Virtus Investment Partners Inc. (NASDAQ: VRTS) 1.2% HIGHER; will replace Carter's in the S&P SmallCap 600 index after the close of trading on Friday, January 13.

Navistar (NYSE: NAV) INDICATED HIGHER; Pentagon has announced the company received an $879 million order for 2,717 blast-proof trucks.

PLX Technology, Inc. (Nasdaq: PLXT) INDICATED LOWER; forecasts the revenue range for Q4 2011 to be $25.7 to $25.9 million compared to previous guidance of $28.0 to $32.0 million. The Street sees revs of $29.9 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

UBS, Citi, RBC Capital, Standard & Poor's, Barclays, After-Hours Movers, Earnings, Wells Fargo